KDM1A and neuroblastoma: Indeed, a new small molecule inhibitor of LSD1—compound 48 (N-(2-(1H-tetrazol-5-yl) phenyl) benzenesulfonamide derivative), synergistically reduced the viability of neuroblastoma cells exposed to bortezomib, a proteasome 26S inhibitor [180].